UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Persistently Elevated C-Reactive Protein Levels and Low Body Mass Index Are Associated with a Lack of Improvement in Bone Mineral Density in Crohn's Disease

Nutrients, 2024-08, Vol.16 (17), p.2827

2024

Volltextzugriff (PDF)

Implementing electronic patient reported outcomes in inflammatory bowel disease: patient participation, score reliability and validity

Health and quality of life outcomes, 2023-01, Vol.21 (1), p.2-2, Article 2

2023

Volltextzugriff (PDF)

Accuracy of Capsule Colonoscopy in Detecting Colorectal Polyps in a Screening Population

Gastroenterology (New York, N.Y. 1943), 2015-05, Vol.148 (5), p.948-957.e2

2015

Volltextzugriff (PDF)

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience

Inflammatory bowel diseases, 2017-03, Vol.23 (3), p.404-408

2017

Volltextzugriff (PDF)

Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients

PloS one, 2018-03, Vol.13 (3), p.e0194166-e0194166

2018

Volltextzugriff (PDF)

Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience

Digestive and liver disease, 2019-01, Vol.51 (1), p.68-74

2019

Volltextzugriff (PDF)

Intermittent Appearance of Antibodies to Infliximab Is Not Associated With Reduced Efficacy in Patients With Inflammatory Bowel Diseases

Journal of clinical gastroenterology, 2022-01, Vol.56 (1), p.e47-e51

2022

Volltextzugriff (PDF)

Distinctive histopathologic phenotype in resection specimens from patients with Crohn’s disease receiving anti–TNF- α therapy

Human pathology, 2014-09, Vol.45 (9), p.1928-1935

2014

Volltextzugriff (PDF)

Heparanase upregulation by colonic epithelium in inflammatory bowel disease

Modern pathology, 2007-01, Vol.20 (1), p.8-14

2007

Volltextzugriff (PDF)

Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium Study

Inflammatory bowel diseases, 2016-10, Vol.22 (10), p.2311-2316

2016

Volltextzugriff (PDF)

COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience

Vaccines (Basel), 2022-02, Vol.10 (3), p.376

2022

Volltextzugriff (PDF)

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD

Gut, 2019-04, Vol.68 (4), p.604-614

2019

Volltextzugriff (PDF)

Sa1786 MESENTERIC FAT PROLIFERATION AND FAT EDEMA ON MAGNETIC RESONANCE ENTEROGRAPHY ARE PREDICTORS OF LONG-TERM DISEASE-RELATED COMPLICATIONS IN CROHN'S DISEASE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-522-S-522

2024

Volltextzugriff (PDF)

Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease

Clinical gastroenterology and hepatology, 2013-04, Vol.11 (4), p.444-447

2013

Volltextzugriff (PDF)

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2018-04, Vol.154 (5), p.1334-1342.e4

2018

Volltextzugriff (PDF)

Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases

Clinical gastroenterology and hepatology, 2018-05, Vol.16 (5), p.697-705.e7

2018

Volltextzugriff (PDF)

Trends in Biochemical Parameters, Healthcare Resource and Medication Use in the 5 Years Preceding IBD Diagnosis: A Health Maintenance Organization Cohort Study

Digestive diseases and sciences, 2023-02, Vol.68 (2), p.414-422

2023

Volltextzugriff (PDF)

Comparative evaluation of a language model and human specialists in the application of European guidelines for the management of inflammatory bowel diseases and malignancies

Endoscopy, 2024-09, Vol.56 (9), p.706-709

2024

Volltextzugriff (PDF)

Su1572: PATTERNS OF MEDICATION USE IN ELDERLY-ONSET INFLAMMATORY BOWEL DISEASE (IBD) - A POPULATION BASED STUDY FROM THE EPIDEMIOLOGIC DATABASE OF THE ISRAEL IBD RESARCH NUCLEUS (EPI-IIRN)

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-636-S-636

2022

Volltextzugriff (PDF)

Su1931 – Does Corticosteroid Therpay Affect Prognosis in Inflammatory Bowel Disease Patients Hospitalized with Clostridium Difficile Infection?

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-665-S-665

2019

Volltextzugriff (PDF)

Tu1971 Fecal Calprotectin Correlates Well With Extent of Active Endoscopic Inflammation in Patients With Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S993-S994

2016

Volltextzugriff (PDF)

Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis

Journal of gastroenterology and hepatology, 2015-01, Vol.30 (1), p.64-70

2015

Volltextzugriff (PDF)

Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN

Journal of Crohn's and colitis, 2022-06, Vol.16 (5), p.786-795

2022

Volltextzugriff (PDF)

Thiopurine hepatotoxicity can mimic intrahepatic cholestasis of pregnancy

Clinics and research in hepatology and gastroenterology, 2020-04, Vol.44 (2), p.e29-e31

2020

Volltextzugriff (PDF)

Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines

Clinical gastroenterology and hepatology, 2017-01, Vol.15 (1), p.69-75

2017

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(71)

Sprache

Englisch
(70)
Hebräisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(37)
Humans
(33)
Gastroenterology & Hepatology
(27)
Male
(22)
Gastroenterology And Hepatology
(20)
Female
(19)
Adult
(17)
Middle Aged
(16)
Crohn's Disease
(12)
Inflammatory Bowel Disease
(11)
Adolescent
(10)
Retrospective Studies
(10)
Ulcerative Colitis
(10)
Infliximab
(9)
Young Adult
(9)
Child
(6)
Crohn Disease - Drug Therapy
(6)
Crohn’s Disease
(6)
Inflammatory Bowel Diseases - Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Persistently Elevated C-Reactive Protein Levels and Low Body Mass Index Are Associated with a Lack of Improvement in Bone Mineral Density in Crohn's Disease

Implementing electronic patient reported outcomes in inflammatory bowel disease: patient participation, score reliability and validity

Accuracy of Capsule Colonoscopy in Detecting Colorectal Polyps in a Screening Population

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience

Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients

Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience

Intermittent Appearance of Antibodies to Infliximab Is Not Associated With Reduced Efficacy in Patients With Inflammatory Bowel Diseases

Distinctive histopathologic phenotype in resection specimens from patients with Crohn’s disease receiving anti–TNF- α therapy

Heparanase upregulation by colonic epithelium in inflammatory bowel disease

Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium Study

COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD

Sa1786 MESENTERIC FAT PROLIFERATION AND FAT EDEMA ON MAGNETIC RESONANCE ENTEROGRAPHY ARE PREDICTORS OF LONG-TERM DISEASE-RELATED COMPLICATIONS IN CROHN'S DISEASE

Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases

Trends in Biochemical Parameters, Healthcare Resource and Medication Use in the 5 Years Preceding IBD Diagnosis: A Health Maintenance Organization Cohort Study

Comparative evaluation of a language model and human specialists in the application of European guidelines for the management of inflammatory bowel diseases and malignancies

Su1572: PATTERNS OF MEDICATION USE IN ELDERLY-ONSET INFLAMMATORY BOWEL DISEASE (IBD) - A POPULATION BASED STUDY FROM THE EPIDEMIOLOGIC DATABASE OF THE ISRAEL IBD RESARCH NUCLEUS (EPI-IIRN)

Su1931 – Does Corticosteroid Therpay Affect Prognosis in Inflammatory Bowel Disease Patients Hospitalized with Clostridium Difficile Infection?

Tu1971 Fecal Calprotectin Correlates Well With Extent of Active Endoscopic Inflammation in Patients With Ulcerative Colitis

Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis

Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN

Thiopurine hepatotoxicity can mimic intrahepatic cholestasis of pregnancy

Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines

Suchergebnisse filtern